| # | Drug | Count |
|---|---|---|
| 0 | RALOXIFENE HYDROCHLORIDE | 53 |
| 1 | ASPIRIN | 30 |
| 2 | ASPIRIN 325 MG | 30 |
| 3 | ASPIRIN 81 MG | 30 |
| 4 | RIVAROXABAN | 29 |
| 5 | DEXAMETHASONE | 28 |
| 6 | DEXAMETHASONE 1.5 MG | 27 |
| 7 | METHOTREXATE | 24 |
| 8 | METHOTREXATE SODIUM | 24 |
| 9 | ATENOLOL | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE | 1 | 0.0270 |
| 1 | PRENATAL SUPPLEMENT WITH DHA | 1 | 0.0227 |
| 2 | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | 1 | 0.0164 |
| 3 | SOY ISOFLAVONES | 1 | 0.0128 |
| 4 | DROSPIRENONE AND ESTRADIOL | 2 | 0.0037 |
| 5 | ISRADIPINE | 2 | 0.0036 |
| 6 | INTERLEUKIN-10 | 1 | 0.0028 |
| 7 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 8 | BUPROPION HCL ER | 1 | 0.0021 |
| 9 | ULIPRISTAL ACETATE | 1 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 71 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 68 |
| 2 | Proton Pump Inhibitor [EPC] | 39 |
| 3 | Factor Xa Inhibitor [EPC] | 32 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 5 | beta-Adrenergic Blocker [EPC] | 31 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 30 |
| 7 | Progestin [EPC] | 29 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 29 |
| 9 | Thalidomide Analog [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 4 | 0.0006 |
| 2 | Photoenhancer [EPC] | 2 | 0.0005 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 6 | 0.0004 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Antiseptic [EPC] | 1 | 0.0002 |
| 8 | Glinide [EPC] | 2 | 0.0002 |
| 9 | Nucleoside Analog Antiviral [EPC] | 17 | 0.0002 |